financetom
Business
financetom
/
Business
/
Chart Industries Q2 profit beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chart Industries Q2 profit beats estimates
Jul 29, 2025 4:13 AM

Overview

* Chart Industries ( GTLS ) Q2 sales rise 4% yr/yr, just missing analyst expectations, per LSEG data

* Adjusted EPS for Q2 beats analyst estimates, rising 18.8% yr/yr, per LSEG data

* Company withdraws 2025 guidance due to proposed acquisition by Baker Hughes ( BKR )

Outlook

* Chart Industries ( GTLS ) withdraws 2025 guidance due to Baker Hughes ( BKR ) acquisition proposal

Result Drivers

* ORDER GROWTH - Orders increased 28.6% yr/yr, driven by demand in hydrogen, LNG, and space exploration segments

* SALES MIX - Sales growth attributed to solutions and aftermarket sales, despite missing analyst expectations

* ADJUSTED EPS - Adjusted EPS rose 18.8%, beating analyst estimates

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Miss $1.08 $1.11

bln bln (12

Analysts

)

Q2 Beat $2.59 $2.46

Adjusted (14

EPS Analysts

)

Q2 EPS $1.53

Q2 $169.50

Operatin mln

g income

Q2 $1.50

Orders bln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

* Wall Street's median 12-month price target for Chart Industries Inc ( GTLS ) is $205.00, about 16.3% above its July 28 closing price of $171.65

* The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 12 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Alcoa Nears Sale of New York Smelter Site to Bitcoin Miner NYDIG
Market Chatter: Alcoa Nears Sale of New York Smelter Site to Bitcoin Miner NYDIG
Apr 17, 2026
01:38 PM EDT, 04/17/2026 (MT Newswires) -- Alcoa ( AA ) is in advanced discussions to sell its former Massena East smelter site in upstate New York to Bitcoin mining firm NYDIG as part of its plan to dispose of unused assets, Bloomberg reported Friday, citing an interview with chief executive officer Bill Oplinger. The deal is expected to close...
Why Delta Air Lines Stock Is Climbing Friday Afternoon
Why Delta Air Lines Stock Is Climbing Friday Afternoon
Apr 17, 2026
Delta Air Lines Inc ( DAL ) shares are trading higher Friday afternoon after Iran said the Strait of Hormuz would remain fully open to commercial vessels during the ceasefire, a development that triggered a sharp drop in oil prices and improved the cost outlook for airlines. Delta Air Lines ( DAL ) shares are powering higher. What’s behind DAL...
F3 Uranium Announces Closing of C$5.5 Million Bought Deal Private Placement
F3 Uranium Announces Closing of C$5.5 Million Bought Deal Private Placement
Apr 17, 2026
01:36 PM EDT, 04/17/2026 (MT Newswires) -- F3 Uranium ( FUUFF ) on Friday said it closed a bought-deal private placement of flow-through shares that raised C$5.55 million, including the partial exercise of the underwriters' over-allotment option. The company said it placed 27.75-million tax-advantaged shares at a price of C$0.20 each. Proceeds will be used to fund exploration programs at...
Kailera surges over 60% in Nasdaq debut as weight-loss drug race heats up
Kailera surges over 60% in Nasdaq debut as weight-loss drug race heats up
Apr 17, 2026
April 17 (Reuters) - Weight-loss drug developer Kailera Therapeutics' shares surged 62.5% in their Nasdaq debut on Friday after closing a $625 million U.S. initial public offering, as Wall Street's appetite for the fast-growing market remains unsated. Success of newer weight-loss therapies have spurred a rush of investment as drugmakers target what is expected to become a $150-billion annual market...
Copyright 2023-2026 - www.financetom.com All Rights Reserved